Vista Pharmaceuticals Share Price

Vista Pharmaceuticals Share Price

  • 7.520.12 (1.62%)
BSE
  • Closed
  • As On: 17 Jun, 2026, 03:40 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)-3.84
EPS - TTM(₹)-1.96
MCap(₹ Cr.)46.29
MCap Rank155
PB Ratio(x)1.25
Div Yield(%)-
Face Value(₹)2.00
52W High(₹)11.87
52W Low(₹)5.71
MCap/Sales6.97
Beta(1 Month)0.70
BV/Share(₹)5.92

Vista Pharma share price insights

  • Losing Shareholder's Money

    Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
  • PAT: Troublesome Times

    Company has posted a loss of Rs 5.86 cr for the 4th consecutive quarter. (Source: Standalone Financials)
  • Employee & Interest Expense

    Company has spent 20.39% of its operating revenues towards interest expenses and 40.73% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Vista Pharma Share Price Update

    Vista Pharmaceuticals Ltd. share price moved up by 1.62% from its previous close of Rs 7.40. Vista Pharmaceuticals Ltd. stock last traded price is 7.52

    Share PriceValue
    Today/Current/Last7.52
    Previous Day7.40

Found Insights useful?

Vista Pharma Share Price Returns

1 Day1.62%
1 Month3.01%
3 Months1.48%
1 Year-32.37%
3 Years-25.54%
5 Years-41.48%

Vista Pharma Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income0.032.511.651.523.47
    Total Income Growth (%)-98.6951.558.97-56.2429.65
    Total Expenses7.255.615.102.814.33
    Total Expenses Growth (%)29.1910.0381.74-35.151.59
    EBIT-7.22-3.10-3.44-1.29-0.86
    EBIT Growth (%)-----
    Profit after Tax (PAT)-5.86-2.32-2.59-1.29-1.50
    PAT Growth (%)-----
    EBIT Margin (%)0.00-123.72-208.13-84.75-24.66
    Net Profit Margin (%)0.00-92.48-156.42-84.97-43.09
    Basic EPS (₹)-0.91-0.41-0.42-0.22-0.79
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue5.7110.5210.621.400.56
    Total Revenue Growth (%)-45.65-1.00656.98150.42-64.65
    Total Expenses21.8715.8115.807.283.12
    Total Expenses Growth (%)38.350.04117.03133.22-40.80
    Profit after Tax (PAT)-12.06-4.65-4.51-5.66-0.83
    PAT Growth (%)-----
    Operating Profit Margin (%)-278.73-42.93-38.46-464.56-420.95
    Net Profit Margin (%)-223.37-46.14-43.85-564.11-210.82
    Basic EPS (₹)-1.96-0.79-1.03-1.54-0.24

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • PAT: Troublesome Times

      Company has posted a loss of Rs 5.86 cr for the 4th consecutive quarter. (Source: Standalone Financials)
    • Employee & Interest Expense

      Company has spent 20.39% of its operating revenues towards interest expenses and 40.73% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets55.0860.2957.9856.0355.59
    Total Assets Growth (%)-8.643.983.480.799.32
    Total Liabilities18.6414.8717.5219.3220.14
    Total Liabilities Growth (%)25.35-15.13-9.32-4.0711.83
    Total Equity36.4445.4240.4636.7135.45
    Total Equity Growth (%)-19.7712.2610.223.557.91
    Current Ratio (x)0.921.191.611.691.43
    Total Debt to Equity (x)0.270.160.200.270.35
    Contingent Liabilities0.00----

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities-4.40-6.98-4.91-1.71-0.99
    Net Cash used in Investing Activities-0.78-0.44-0.79-1.27-0.01
    Net Cash flow from Financing Activities4.568.065.593.110.94
    Net Cash Flow-0.630.64-0.110.13-0.07
    Closing Cash & Cash Equivalent0.110.730.090.200.07
    Closing Cash & Cash Equivalent Growth (%)-85.41675.98-53.68183.33-48.57
    Total Debt/ CFO (x)-2.27-1.06-1.62-5.82-12.64

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Increase in Cash from Investing

      Company has used Rs 0.78 cr for investing activities which is an YoY increase of 77.75%. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)-33.09-10.23-11.15-15.42-2.34
    Return on Capital Employed (%)-39.15-9.02-9.10-11.11-3.70
    Return on Assets (%)-21.89-7.71-7.78-10.10-1.49
    Interest Coverage Ratio (x)-12.99-3.72-2.65-3.33-1.16
    Asset Turnover Ratio (x)0.090.170.180.020.01
    Price to Earnings (x)-3.12-14.22-11.15-5.55-40.82
    Price to Book (x)1.031.461.240.860.96
    EV/EBITDA (x)-3.32-20.29-17.96-10.17-44.41
    EBITDA Margin (%)-264.86-35.61-31.47-403.02-264.79

    No Data Available

    Insights
    • Losing Shareholder's Money

      Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters1,30,40,18721.19 %0.00
    Pledge00.00 %0.00
    DII14,1660.02 %0.00
    MF14,1660.02 %0.00
    Others4,84,97,55478.78 %0.00
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters21.1921.1921.1921.19
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.020.020.020.02
    Mutual Funds0.020.020.020.02
    Others78.7878.7878.7878.78

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Audited Results

    May 19, 2026

    Board Meeting

    Quarterly Results

    Feb 05, 2026

    Board Meeting

    Quarterly Results

    Nov 04, 2025

  • Announced onMeeting on
    May 19, 2026May 29, 2026
    Audited Results
    Feb 05, 2026Feb 13, 2026
    Quarterly Results
    Nov 04, 2025Nov 13, 2025
    Quarterly Results
    Aug 06, 2025Aug 13, 2025
    Quarterly Results
    May 20, 2025May 30, 2025
    Audited Results
  • No Data Available

  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Sep 15, 2025Sep 30, 2025
    -
    Feb 25, 2025Mar 20, 2025
    -
    Sep 19, 2024Sep 30, 2024
    A.G.M.
    Sep 06, 2023Sep 30, 2023
    -
    Aug 13, 2022Sep 29, 2022
    -

About Vista Pharma

Vista Pharmaceuticals Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 46.29 Crore) operating in Pharmaceuticals sector.

Show More

Key Indices Listed On

-

Address

Plot Nos. 10 to 14 and 16 to 20,TSIIC Industrial Estate,Narketpalli Mandal,Nalgonda District, Telangana - 508254

Executive Leadership

DA

Dhananjaya Alli

Chairman & Wholetime Director
MM

Murali Meraga

Managing Director
PS

Pavan Sathvik Gilaka

Whole Time Director
DR

Divakar Reddy Yerrabommanahalli

Non Executive Director
Show More

Auditors

A M Reddy & D R Reddy
Mahesh, Virender & Sriram

FAQs about Vista Pharma share

  • 1. What's the Vista Pharma share price today?
    Vista Pharma share price is Rs 7.52 as on 17 Jun, 2026, 03:40 PM IST. Vista Pharma share price is up by 1.62% based on previous share price of Rs. 7.22.
  • 2. What has been highest price of Vista Pharma share in last 52 weeks?
    52 Week high of Vista Pharma share is Rs 11.87 while 52 week low is Rs 5.71
  • 3. What's the market capitalization of Vista Pharma?
    Vista Pharma share has a market capitalization of Rs 46.29 Cr. Within Pharmaceuticals sector, it's market cap rank is 155.
  • 4. What is the PE & PB ratio of Vista Pharma?
    The PE ratio of Vista Pharma stands at -3.78, while the PB ratio is 1.25.
  • 5. What are the returns for Vista Pharma share?
    Return Performance of Vista Pharma Shares:
    • 1 Week: Vista Pharma share price moved up by 2.17%

Top Gainers

As on 03:59 PM | 17 Jun 2026
IDBI Bank
90.36
13.21 (17.13%)
Schneider
1,266.60
85.20 (7.22%)
UCO Bank
28.20
1.88 (7.11%)
Trent
3,102.80
205.00 (7.08%)
Olectra Greentech
1,354.90
84.50 (6.66%)

Top Losers

As on 03:59 PM | 17 Jun 2026
Tata Motors PV
360.95
-32.66 (-8.30%)
BSE
3,999.20
-163.20 (-3.93%)
Aarti Inds
479.20
-17.50 (-3.53%)
Cyient
876.15
-31.50 (-3.48%)
FACT
967.60
-30.20 (-3.03%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.